Compare First Citizens BancShares Inc (FCNCA) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Citizens BancShares Inc vs uniQure N.V. Ordinary Shares — how do they compare? First Citizens BancShares Inc trades at $2,052.8 (market cap $22.80B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: First Citizens BancShares Inc is far larger — about 15.7× uniQure N.V. Ordinary Shares's market cap, and First Citizens BancShares Inc pays a 0.41% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold First Citizens BancShares Inc for 30 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| FCNCA | QURE | |
|---|---|---|
Market Cap | $22.80B | $1.45B |
Volume | 44,337 | 3,323,243 |
Sector | Sector/Thematic | Health |
52-Week High | $2.29K | $70.59 |
52-Week Low | $1.64K | $9.03 |
Typical Hold Time | 30 Days | 0 Days |
Dividend Yield | 0.41% | — |
Enterprise Value | — | $707.46M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FCNCA trades at $2,075.12, down 0.35% on the day, with a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings of $57.09 per share, beating estimates, and maintains a net income margin of 25.23%. Recent news includes a $157 million financing deal and branch expansion initiatives, signaling growth. Cash flow improved to a net positive $630 million in 2026 from a slight deficit in 2025.
The outlook is mixed: solid profitability and earnings beats support upside toward the $2,290 consensus price target, but technical bearishness and high institutional hold ratings suggest near-term caution. Key risks include execution of expansion and interest rate sensitivity. The stock offers value with a P/E of 11.13, yet requires monitoring of technical levels for entry.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
